RJFSA
OMGA

Raymond James Financial Services Advisors’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Raymond James Financial Services Advisors’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$72.6K Buy
59,474
+21,307
+56% +$33.9K ﹤0.01% 3329
2024
Q2 		$79K Buy
+38,167
New +$90K ﹤0.01% 3269

Other funds holding OMGA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Raymond James Financial Services Advisors's OMGA Position: Q3 2024 in Review

Raymond James Financial Services Advisors increased its Omega Therapeutics, Inc. Common Stock (OMGA) stake by 56% in Q3 2024, buying an estimated $33.9K and bringing the position to 59,474 shares worth $72.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3329.

Raymond James Financial Services Advisors first reported a position in OMGA in Q2 2024 and has held it in 2 quarters since. The position peaked at $79K in Q2 2024. 54 funds tracked by Wall St. Rank hold OMGA as of Q3 2024.

  • Raymond James Financial Services Advisors held 59,474 shares of Omega Therapeutics, Inc. Common Stock worth $72.6K as of Q3 2024.
  • Raymond James Financial Services Advisors bought 21,307 Omega Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $33.9K.
  • Omega Therapeutics, Inc. Common Stock made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #3329 holding.
  • Raymond James Financial Services Advisors first reported a position in Omega Therapeutics, Inc. Common Stock in Q2 2024 and has held it in 2 quarters since.
  • Raymond James Financial Services Advisors's Omega Therapeutics, Inc. Common Stock position peaked at $79K in Q2 2024.
  • 54 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.